您的位置: 首页 > 农业专利 > 详情页

IL-17 Antagonist Antibodies
专利权人:
Novartis AG
发明人:
Di Padova, Franco E,Gram, Hermann,Hofstetter, Hans,Jeschke, Margit,Rondeau, Jean-Michel,Van Den Berg, Wim
申请号:
ES15156029
公开号:
ES2677245T3
申请日:
2005.08.04
申请国别(地区):
ES
年份:
2018
代理人:
摘要:
An IL-17 binding antibody or fragment thereof comprising both heavy chain (VH) and light chain (VL) variable domains for use in the treatment of an inflammatory arthritis, wherein said IL-17 binding antibody or fragment thereof comprises at least one antigen binding site comprising: (a) a VH comprising in sequence the hypervariable regions CDR1, CDR2 and CDR3, said CDR1 having the amino acid sequence SEQ ID NO: 1, said CDR2 having the amino acid sequence SEQ ID NO: 2, and said CDR3 having the amino acid sequence SEQ ID NO: 3, wherein the hypervariable regions are in accordance with the definition of Kabat; or (b) a VH comprising in sequence the hypervariable regions CDR1-x, CDR2-x and CDR3-x, said CDR1-x having the amino acid sequence SEQ ID NO: 11, said CDR2-x having the amino acid sequence SEQ ID NO: 12, and said CDR3-x having the amino acid sequence SEQ ID NO: 13, wherein the hypervariable regions are in accordance with the definition of Chothia; and (c) a VL comprising in sequence the hypervariable regions CDR1 ', CDR2' and CDR3 ', said CDR1' having the amino acid sequence SEQ ID NO: 4, said CDR2 'having the amino acid sequence SEQ ID NO: 5, and said CDR3 'having the amino acid sequence SEQ ID NO: 6 wherein the hypervariable regions are in accordance with Kabat's definition.Un anticuerpo de unión a IL-17 o fragmento del mismo que comprende dominios variables tanto de cadena pesada (VH) como de cadena ligera (VL) para uso en el tratamiento de una artritis inflamatoria, en donde dicho anticuerpo de unión a IL-17 o fragmento del mismo comprende al menos un sitio de unión a antígeno que comprende: (a) un VH que comprende en secuencia las regiones hipervariables CDR1, CDR2 y CDR3, teniendo dicha CDR1 la secuencia de aminoácidos SEQ ID NO: 1, teniendo dicha CDR2 la secuencia de aminoácidos SEQ ID NO: 2, y teniendo dicha CDR3 la secuencia de aminoácidos SEQ ID NO: 3, en donde las regiones hipervariables están de acuerdo con la definición de Kabat; o (b) un VH que compr
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充